• Find a Retina Specialist
• Retina Career Center
• Report Adverse Event
• About ASRS
• Foundation
• Corporate

Retinal Artery Occlusions Bibliography

Bitra R, Eggenberger E. Review of Susac syndrome. Curr Opin Ophthalmol. 2011;22(6):472–476. doi:10.1097/ICU.0b013e32834bbfeb.

Callizo J, Feltgen N, Pantenburg S, et al; European Assessment Group for Lysis in the Eye. Cardiovascular risk factors in central retinal artery occlusion: results of a prospective and standardized medical examination [published online July 21, 2015]. Ophthalmology. 2015;122(9):1881-1888. doi:10.1016/j.ophtha.2015.05.044.

Chodnicki KD, Tanke LB, Pulido JS, Hodge DO, Klaas JP, Olsen TW, Bhatti MT, Chen JJ.  Stroke Risk before and after Central Retinal Artery Occlusion: A Population-based Analysis.  Ophthalmology. 2022 Feb;129(2):203-208. doi: 10.1016/j.ophtha.2021.07.017. Epub 2021 Jul 23. PMID: 34303745.

Dattilo M, Biousse V, Newman NJ. Update on the Management of Central Retinal Artery Occlusion. Neurol Clin. 2017 Feb;35(1):83-100. doi: 10.1016/j.ncl.2016.08.013. PMID: 27886897.

Flaxel CJ, Adelman RA, Bailey ST, Fawzi A, Lim JI, Vemulakonda GA, Ying GS. Retinal and Ophthalmic Artery Occlusions Preferred Practice Pattern®. Ophthalmology. 2020 Feb;127(2):P259-P287. doi: 10.1016/j.ophtha.2019.09.028. Epub 2019 Sep 25. Erratum in: Ophthalmology. 2020 Sep;127(9):1280. doi: 10.1016/j.ophtha.2020.06.044. PMID: 31757501.

Greco A, De Virgilio A, Gallo A, et al. Susac’s syndrome—pathogenesis, clinical variants and treatment approaches [published online April 12, 2014]. Autoimmun Rev. 2014;13(8):814–821. doi:10.1016/j.autrev.2014.04.004.

Hattenbach LO, Kuhli-Hattenback C, Scharrer I, Baatz H. Intravenous thrombolysis with low-dose recombinant tissue plasminogen activator in central retinal artery occlusion [published online August 21, 2008]. Am J Ophthalmol. 2008;146(5):700-706.e1. doi:10.1016/j.ajo.2008.06.016.

Hayreh SS, Zimmerman MB. Central retinal artery occlusion: visual outcome. Am J Ophthalmol. 2005;140(3):376.e1-376.e18. doi:10.1016/j.ajo.2005.03.038.

Hayreh SS, Zimmerman MB, Kimura A, Sanon A. Central retinal artery occlusion: retinal survival time. Exp Eye Res. 2004;78(3):723-736. doi:10.1016/S0014-4835(03)00214-8.

Lin JC, Song S, Ng SM, Scott IU, Greenberg PB.Interventions for acute non-arteritic central retinal artery occlusion. Cochrane Database Syst Rev. 2023 Jan 30;1(1):CD001989. doi: 10.1002/14651858.CD001989.pub3.
PMID: 36715340 Review.

Mac Grory B, Schrag M, Biousse V, Furie KL, Gerhard-Herman M, Lavin PJ, Sobrin L, Tjoumakaris SI, Weyand CM, Yaghi S;  Management of Central Retinal Artery Occlusion: A Scientific Statement From the American Heart Association.  American Heart Association Stroke Council; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Hypertension; and Council on Peripheral Vascular Disease.
Stroke. 2021 Jun;52(6):e282-e294. doi: 10.1161/STR.0000000000000366. Epub 2021 Mar 8.
PMID: 33677974 Review.

Petzold A, Islam N, Hu HH, Plant GT. Embolic and nonembolic transient monocular visual field loss: a clinicopathologic review. Surv Ophthalmol. 2013;58(1):42-62. doi:10.1016/j.survophthal.2012.02.002.

Pielen A, Pantenburg S, Schmoor C, et al; EAGLE Study Group. Predictors of prognosis and treatment outcome in central retinal artery occlusion: local intra-arterial fibrinolysis vs. conservative treatment [published online September 8, 2015]. Neuroradiology. 2015;57(10):1055-1062. doi:10.1007/s00234-015-1588-3. 

Schumacher M, Schmidt D, Jurklies B, et al; EAGLE-Study Group. Central retinal artery occlusion: local intra-arterial fibrinolysis versus conservative treatment, a multicenter randomized trial. Ophthalmology. 2010;117(7):1367-1375. doi:10.1016/j.ophtha.2010.03.061.

Thangamathesvaran L, Miller SC, Tsou B, Fliotsos MJ, Yonekawa Y, Chen A, Hoskin AK, Blanch RJ, Cavuoto K, Meeralakshmi P, Low R, Gardiner M, Alvin Liu TY, Agrawal R, Justin GA, Woreta FA; International Globe and Adnexal Trauma Epidemiology Study (IGATES).  Global Current Practice Patterns for the Management of Central Retinal Artery Occlusion. Ophthalmol Retina. 2022 Jan 28:S2468-6530(22)00036-7. doi: 10.1016/j.oret.2022.01.014. Online ahead of print. PMID: 35101631.

Vestergaard N, Torp-Pedersen C, Vorum H, Aasbjerg K.  Risk of Stroke, Myocardial Infarction, and Death Among Patients With Retinal Artery Occlusion and the Effect of Antithrombotic Treatment. 
Transl Vis Sci Technol. 2021 Sep 1;10(11):2. doi: 10.1167/tvst.10.11.2.
PMID: 34468694 Free PMC article.

Youn TS, Lavin P, Patrylo M, et al. Current treatment of central retinal artery occlusion: a national survey [published online ahead of print December 13, 2017]. J Neurol. doi:0.1007/s00415-017-8702-x.

Yousuf SJ, Guiseppi R, Katz DM, Nnorom SO, Akinyemi OA.  Emergency Department Presentation of Retinal Artery Occlusion.  Ophthalmol Retina. 2021 Nov 3:S2468-6530(21)00349-3. doi: 10.1016/j.oret.2021.10.011. Online ahead of print. PMID: 34742898.